{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:41:52Z","timestamp":1793011312845,"version":"4.5.0"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s10571-023-01330-y","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T08:03:03Z","timestamp":1677484983000},"page":"2491-2523","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Shital","family":"Rani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhrita Basu","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Khajuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dikshi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-4657","authenticated-orcid":false,"given":"Mandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1665-145X","authenticated-orcid":false,"given":"Gurpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-5357","authenticated-orcid":false,"given":"Ravi Pratap","family":"Barnwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.clinph.2005.04.001","volume":"116","author":"D Ab\u00e1solo","year":"2005","unstructured":"Ab\u00e1solo D, Hornero R, Espino P et al (2005) Analysis of regularity in the EEG background activity of Alzheimer\u2019s disease patients with Approximate Entropy. Clin Neurophysiol 116:1826\u20131834","journal-title":"Clin Neurophysiol"},{"key":"1330_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s11517-008-0392-1","volume":"46","author":"D Ab\u00e1solo","year":"2008","unstructured":"Ab\u00e1solo D, Escudero J, Hornero R et al (2008) Approximate entropy and auto mutual information analysis of the electroencephalogram in Alzheimer\u2019s disease patients. Med Biol Eng Comput 46:1019\u20131028","journal-title":"Med Biol Eng Comput"},{"key":"1330_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/med.21534","volume":"39","author":"Y Abdoul","year":"2019","unstructured":"Abdoul Y, Mahaman R, Afewerky HK et al (2019) Involvement of calpain in the neuropathogenesis of Alzheimer\u2019s disease. Med Res Rev 39:608\u2013630. https:\/\/doi.org\/10.1002\/med.21534","journal-title":"Med Res Rev"},{"key":"1330_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2014.00266","volume":"6","author":"J Acosta-Cabronero","year":"2014","unstructured":"Acosta-Cabronero J, Nestor PJ (2014) Diffusion tensor imaging in Alzheimer\u2019s disease: insights into the limbic-diencephalic network and methodological considerations. Front Aging Neurosci 6:1\u201321. https:\/\/doi.org\/10.3389\/fnagi.2014.00266","journal-title":"Front Aging Neurosci"},{"key":"1330_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-022-00937-4","volume":"15","author":"HK Alajangi","year":"2022","unstructured":"Alajangi HK, Kaur M, Sharma A et al (2022) Blood\u2013brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders. Mol Brain 15:1\u201328. https:\/\/doi.org\/10.1186\/s13041-022-00937-4","journal-title":"Mol Brain"},{"key":"1330_CR6","first-page":"365","volume":"3","author":"PN Alexandrov","year":"2012","unstructured":"Alexandrov PN, Dua P, Hill JM et al (2012) MicroRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 3:365\u2013373","journal-title":"Int J Biochem Mol Biol"},{"key":"1330_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8915079","volume":"2018","author":"AHH Al-Nuaimi","year":"2018","unstructured":"Al-Nuaimi AHH, Jammeh E, Sun L, Ifeachor E (2018) Complexity measures for quantifying changes in electroencephalogram in Alzheimer\u2019s disease. Complexity 2018:1\u201312","journal-title":"Complexity"},{"key":"1330_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2020.595532","volume":"11","author":"C Alquezar","year":"2021","unstructured":"Alquezar C, Arya S, Kao AW (2021) Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation. Front Neurol 11:1\u201324. https:\/\/doi.org\/10.3389\/fneur.2020.595532","journal-title":"Front Neurol"},{"key":"1330_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.bbadis.2008.07.008","volume":"1782","author":"CD Aluise","year":"2008","unstructured":"Aluise CD, Sowell RA, Butterfield DA (2008) Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer\u2019s disease. Biochim Biophys Acta 1782:549\u2013558. https:\/\/doi.org\/10.1016\/j.bbadis.2008.07.008","journal-title":"Biochim Biophys Acta"},{"key":"1330_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/BEN-2009-0225","volume":"21","author":"J Appel","year":"2009","unstructured":"Appel J, Potter E, Shen Q et al (2009) A comparative analysis of structural brain MRI in the diagnosis of Alzheimer\u2019s disease. Behav Neurol 21:13\u201319. https:\/\/doi.org\/10.3233\/BEN-2009-0225","journal-title":"Behav Neurol"},{"key":"1330_CR11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ana.410380414","volume":"38","author":"H Arai","year":"1995","unstructured":"Arai H, Terajima M, Miura M et al (1995) Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer\u2019s disease. Ann Neurol 38:649\u2013652. https:\/\/doi.org\/10.1002\/ana.410380414","journal-title":"Ann Neurol"},{"key":"1330_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/WNL.0000000000005303","volume":"90","author":"EM Arenaza-Urquijo","year":"2018","unstructured":"Arenaza-Urquijo EM, Vemuri P (2018) Resistance vs resilience to Alzheimer disease. Neurology 90:695\u2013703. https:\/\/doi.org\/10.1212\/WNL.0000000000005303","journal-title":"Neurology"},{"key":"1330_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13195-020-00609-2","volume":"12","author":"EM Arenaza-Urquijo","year":"2020","unstructured":"Arenaza-Urquijo EM, Vemuri P (2020) Improving the resistance and resilience framework for aging and dementia studies. Alzheimer\u2019s Res Ther 12:10\u201313. https:\/\/doi.org\/10.1186\/s13195-020-00609-2","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1330_CR14","first-page":"87","volume":"57","author":"RA Armstrong","year":"2019","unstructured":"Armstrong RA (2019) Risk factors for alzheimer disease. [Factores de riesgo para la enfermedad de Alzheimer]. Brain Nerve 57:87\u2013105","journal-title":"Brain Nerve"},{"key":"1330_CR15","doi-asserted-by":"publisher","first-page":"00231","DOI":"10.3389\/fnagi.2020.00231","volume":"12","author":"J Arslan","year":"2020","unstructured":"Arslan J, Jamshed H, Qureshi H (2020) Early detection and prevention of Alzheimer\u2019s disease: role of oxidative markers and natural antioxidants. Front Aging Neurosci 12:00231. https:\/\/doi.org\/10.3389\/fnagi.2020.00231","journal-title":"Front Aging Neurosci"},{"key":"1330_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm10030114","volume":"10","author":"E Aus\u00f3","year":"2020","unstructured":"Aus\u00f3 E, G\u00f3mez-Vicente V, Esquiva G (2020) Biomarkers for alzheimer\u2019s disease early diagnosis. J Pers Med 10:1\u201327. https:\/\/doi.org\/10.3390\/jpm10030114","journal-title":"J Pers Med"},{"key":"1330_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3325\/cmj.2014.55.347","volume":"55","author":"M Babi\u0107","year":"2014","unstructured":"Babi\u0107 M, \u0160trac D\u0160, M\u00fcck-\u0160eler D et al (2014) Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease. Croat Med J 55:347\u2013365. https:\/\/doi.org\/10.3325\/cmj.2014.55.347","journal-title":"Croat Med J"},{"key":"1330_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai B, Vanderwall D, Li Y et al (2021) Proteomic landscape of Alzheimer\u2019s Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener 16:1\u201316. https:\/\/doi.org\/10.1186\/s13024-021-00474-z","journal-title":"Mol Neurodegener"},{"key":"1330_CR19","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1074\/mcp.O115.056986","volume":"15","author":"CE Bakalarski","year":"2016","unstructured":"Bakalarski CE, Kirkpatrick DS (2016) A biologist\u2019s field guide to multiplexed quantitative proteomics. Mol Cell Proteomics 15:1489\u20131497. https:\/\/doi.org\/10.1074\/mcp.O115.056986","journal-title":"Mol Cell Proteomics"},{"key":"1330_CR20","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.15252\/embj.201387576","volume":"33","author":"J Banzhaf-strathmann","year":"2014","unstructured":"Banzhaf-strathmann J, Benito E, May S et al (2014) MicroRNA- 125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer\u2019s disease. EMBO J 33:1667\u20131680","journal-title":"EMBO J"},{"key":"1330_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7556\/jaoa.2010.20041","volume":"110","author":"RC Barber","year":"2010","unstructured":"Barber RC (2010) Biomarkers for early detection of Alzheimer disease. J Am Osteopath Assoc 110:10\u201315. https:\/\/doi.org\/10.7556\/jaoa.2010.20041","journal-title":"J Am Osteopath Assoc"},{"key":"1330_CR22","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ejcn.2014.176","volume":"68","author":"C Bastin","year":"2014","unstructured":"Bastin C, Salmon E (2014) Early neuropsychological detection of Alzheimer\u2019s disease. Eur J Clin Nutr 68:1192\u20131199. https:\/\/doi.org\/10.1038\/ejcn.2014.176","journal-title":"Eur J Clin Nutr"},{"key":"1330_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0279-z","volume":"13","author":"B Becker","year":"2018","unstructured":"Becker B, Nazir FH, Brinkmalm G et al (2018) Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase. Mol Neurodegener 13:1\u201312","journal-title":"Mol Neurodegener"},{"key":"1330_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE et al (2022) New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet 54:412\u2013436. https:\/\/doi.org\/10.1038\/s41588-022-01024-z","journal-title":"Nat Genet"},{"key":"1330_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.npg.2018.11.006","volume":"19","author":"S Benhalla","year":"2019","unstructured":"Benhalla S, El Moutawakil B, El Kadmiri N, Nadifi S (2019) The genetics of Alzheimer\u2019s disease. NPG Neurol Psychiatr Geriatr 19:83\u201390. https:\/\/doi.org\/10.1016\/j.npg.2018.11.006","journal-title":"NPG Neurol Psychiatr Geriatr"},{"key":"1330_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S1388-2457(99)00309-0","volume":"111","author":"HW Berendse","year":"2000","unstructured":"Berendse HW, Verbunt JPA, Scheltens P et al (2000) Magnetoencephalographic analysis of cortical activity in Alzheimer\u2019s disease: a pilot study. Clin Neurophysiol 111:604\u2013612. https:\/\/doi.org\/10.1016\/S1388-2457(99)00309-0","journal-title":"Clin Neurophysiol"},{"key":"1330_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116055","author":"M Berrocal","year":"2021","unstructured":"Berrocal M, Saez L, Mata AM (2021) Sorcin activates the brain pmca and blocks the inhibitory effects of molecular markers of alzheimer\u2019s disease on the pump activity. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22116055","journal-title":"Int J Mol Sci"},{"key":"1330_CR28","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","volume":"17","author":"BM Bettcher","year":"2021","unstructured":"Bettcher BM, Tansey MG, Doroth\u00e9e G, Heneka MT (2021) Peripheral and central immune system crosstalk in Alzheimer disease \u2014 a research prospectus. Nat Rev Neurol 17:689\u2013701. https:\/\/doi.org\/10.1038\/s41582-021-00549-x","journal-title":"Nat Rev Neurol"},{"key":"1330_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","volume":"6","author":"K Blennow","year":"2017","unstructured":"Blennow K (2017) A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood. Neurol Ther 6:15\u201324. https:\/\/doi.org\/10.1007\/s40120-017-0073-9","journal-title":"Neurol Ther"},{"key":"1330_CR30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-2009-1177","volume":"18","author":"K Blennow","year":"2009","unstructured":"Blennow K, Zetterberg H (2009) Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 18:413\u2013417. https:\/\/doi.org\/10.3233\/JAD-2009-1177","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H (1995) tau protein in cerebrospinal fluid A biochemical marker. Mol Chem Neuropathol 26:231\u2013245","journal-title":"Mol Chem Neuropathol"},{"key":"1330_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131\u2013144. https:\/\/doi.org\/10.1038\/nrneurol.2010.4","journal-title":"Nat Rev Neurol"},{"key":"1330_CR33","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.biocel.2011.02.009","volume":"43","author":"S Bolognin","year":"2011","unstructured":"Bolognin S, Messori L, Drago D et al (2011) Aluminum, copper, iron and zinc differentially alter amyloid-A\u03b21\u201342 aggregation and toxicity. Int J Biochem Cell Biol 43:877\u2013885","journal-title":"Int J Biochem Cell Biol"},{"key":"1330_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1259\/bjr.75.894.750506","volume":"75","author":"KM Bradley","year":"2002","unstructured":"Bradley KM, Bydder GM, Budge MM et al (2002) Serial brain MRI at 3\u20136 month intervals as a surrogate marker for Alzheimer\u2019s disease. Br J Radiol 75:506\u2013513. https:\/\/doi.org\/10.1259\/bjr.75.894.750506","journal-title":"Br J Radiol"},{"key":"1330_CR35","doi-asserted-by":"publisher","first-page":"120644","DOI":"10.1016\/j.talanta.2019.120644","volume":"210","author":"LC Brazaca","year":"2020","unstructured":"Brazaca LC, Sampaio I, Zucolotto V, Janegitz BC (2020) Talanta Applications of biosensors in Alzheimer \u2019 s disease diagnosis. Talanta 210:120644. https:\/\/doi.org\/10.1016\/j.talanta.2019.120644","journal-title":"Talanta"},{"key":"1330_CR36","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1093\/brain\/awac013","volume":"145","author":"C Bridel","year":"2022","unstructured":"Bridel C, Somers C, Sieben A et al (2022) Associating Alzheimer\u2019s disease pathology with its cerebrospinal fluid biomarkers. Brain 145:4056\u20134064","journal-title":"Brain"},{"key":"1330_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1750-1326-9-53","volume":"9","author":"A Brinkmalm","year":"2014","unstructured":"Brinkmalm A, Brinkmalm G, Honer WG et al (2014) SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer\u2019s disease. Mol Neurodegener 9:53. https:\/\/doi.org\/10.1186\/1750-1326-9-53","journal-title":"Mol Neurodegener"},{"key":"1330_CR38","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1111\/jnc.15175","volume":"157","author":"F Brosseron","year":"2021","unstructured":"Brosseron F, Kleemann K, Kolbe CC et al (2021) Interrelations of Alzheimer\u00b4s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation. J Neurochem 157:2210\u20132224. https:\/\/doi.org\/10.1111\/jnc.15175","journal-title":"J Neurochem"},{"key":"1330_CR39","first-page":"37","volume-title":"An overview of light and electron microscopic changes","author":"A Brun","year":"1983","unstructured":"Brun A (1983) An overview of light and electron microscopic changes. Free Press, New York, pp 37\u201347"},{"key":"1330_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1373\/jalm.2019.030080","volume":"5","author":"MM Budelier","year":"2020","unstructured":"Budelier MM, Bateman RJ (2020) Biomarkers of Alzheimer disease. J Appl Lab Med 5:194\u2013208. https:\/\/doi.org\/10.1373\/jalm.2019.030080","journal-title":"J Appl Lab Med"},{"key":"1330_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","volume":"53","author":"SF Carter","year":"2012","unstructured":"Carter SF, Sch\u00f6ll M, Almkvist O et al (2012) Evidence for astrocytosis in prodromal alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med 53:37\u201346. https:\/\/doi.org\/10.2967\/jnumed.110.087031","journal-title":"J Nucl Med"},{"key":"1330_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-020-01137-1","volume":"11","author":"P Chatterjee","year":"2021","unstructured":"Chatterjee P, Pedrini S, Stoops E et al (2021) Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease. Transl Psychiatry 11:1\u201310","journal-title":"Transl Psychiatry"},{"key":"1330_CR43","doi-asserted-by":"publisher","DOI":"10.1109\/TVCG.2019.2934332","author":"Z Chen","year":"2019","unstructured":"Chen Z, Zeng W, Yang Z et al (2019) LassoNet: deep lasso-selection of 3D point clouds. IEEE Trans vis Comput Graph. https:\/\/doi.org\/10.1109\/TVCG.2019.2934332","journal-title":"IEEE Trans vis Comput Graph"},{"key":"1330_CR44","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/mp.2014.127","volume":"20","author":"L Cheng","year":"2015","unstructured":"Cheng L, Doecke JD, Sharples RA et al (2015) Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20:1188\u20131196. https:\/\/doi.org\/10.1038\/mp.2014.127","journal-title":"Mol Psychiatry"},{"key":"1330_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11307-018-1167-1","volume":"20","author":"A Chiaravalloti","year":"2018","unstructured":"Chiaravalloti A, Castellano AE, Ricci M et al (2018) Coupled imaging with [18F]FBB and [18F]FDG in AD subjects show a selective association between amyloid burden and cortical dysfunction in the brain. Mol Imaging Biol 20:659\u2013666. https:\/\/doi.org\/10.1007\/s11307-018-1167-1","journal-title":"Mol Imaging Biol"},{"key":"1330_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/JAD-122059","volume":"34","author":"DT Chien","year":"2013","unstructured":"Chien DT, Bahri S, Szardenings AK et al (2013) Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. J Alzheimer\u2019s Dis 34:457\u2013468. https:\/\/doi.org\/10.3233\/JAD-122059","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR47","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.33549\/physiolres.933601","volume":"66","author":"Z Chmatalova","year":"2017","unstructured":"Chmatalova Z, Vyhnalek M, Laczo J et al (2017) Relation of plasma selenium and lipid peroxidation end products in patients with Alzheimer\u2019s disease. Physiol Res 66:1049\u20131056. https:\/\/doi.org\/10.33549\/physiolres.933601","journal-title":"Physiol Res"},{"key":"1330_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pneurobio.2005.02.004","volume":"75","author":"ZZ Chong","year":"2005","unstructured":"Chong ZZ, Li F, Maiese K (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75:207\u2013246. https:\/\/doi.org\/10.1016\/j.pneurobio.2005.02.004","journal-title":"Prog Neurobiol"},{"key":"1330_CR49","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00259-018-4149-2","volume":"46","author":"A Ciarmiello","year":"2019","unstructured":"Ciarmiello A, Tartaglione A, Giovannini E et al (2019) Amyloid burden identifies neuropsychological phenotypes at increased risk of progression to Alzheimer\u2019s disease in mild cognitive impairment patients. Eur J Nucl Med Mol Imaging 46:288\u2013296. https:\/\/doi.org\/10.1007\/s00259-018-4149-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1330_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000109754","volume":"16","author":"CM Clark","year":"2007","unstructured":"Clark CM, Davatzikos C, Borthakur A et al (2007) Biomarkers for early detection of Alzheimer pathology. Neurosignals 16:11\u201318. https:\/\/doi.org\/10.1159\/000109754","journal-title":"Neurosignals"},{"key":"1330_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00588-4","volume":"12","author":"M Colom-Cadena","year":"2020","unstructured":"Colom-Cadena M, Spires-Jones T, Zetterberg H et al (2020) The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 12:1\u201312. https:\/\/doi.org\/10.1186\/s13195-020-00588-4","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1330_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","volume":"14","author":"SE Counts","year":"2017","unstructured":"Counts SE, Ikonomovic MD, Mercado N et al (2017) Biomarkers for the early detection and progression of Alzheimer\u2019s disease. Neurotherapeutics 14:35\u201353. https:\/\/doi.org\/10.1007\/s13311-016-0481-z","journal-title":"Neurotherapeutics"},{"key":"1330_CR53","volume-title":"A novel tau binding partner SERPINA5 Results Bulk transcriptional profiling of hippocampal vulnerability in AD","author":"AM Crist","year":"2020","unstructured":"Crist AM, Hinkle KM, Wang X et al (2020) A novel tau binding partner SERPINA5 Results Bulk transcriptional profiling of hippocampal vulnerability in AD. Springer, New York"},{"key":"1330_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/156720506778249461","volume":"3","author":"C Culmsee","year":"2006","unstructured":"Culmsee C, Landshamer S (2006) Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders. Curr Alzheimer Res 3:269\u2013283. https:\/\/doi.org\/10.2174\/156720506778249461","journal-title":"Curr Alzheimer Res"},{"key":"1330_CR55","doi-asserted-by":"publisher","first-page":"17049","DOI":"10.1074\/jbc.M802912200","volume":"283","author":"E Czirr","year":"2008","unstructured":"Czirr E, Cottrell BA, Leuchtenberger S et al (2008) Independent generation of A\u03b242 and A\u03b238 peptide species by \u03b3-secretase. J Biol Chem 283:17049\u201317054","journal-title":"J Biol Chem"},{"key":"1330_CR56","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1021\/bi0004807","volume":"39","author":"NL Daly","year":"2000","unstructured":"Daly NL, Hoffmann R, Otvos L, Craik DJ (2000) Role of phosphorylation in the conformation of \u03c4 peptides implicated in alzheimer\u2019s disease. Biochemistry 39:9039\u20139046. https:\/\/doi.org\/10.1021\/bi0004807","journal-title":"Biochemistry"},{"key":"1330_CR57","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/gps.4036","volume":"29","author":"CM Davison","year":"2014","unstructured":"Davison CM, O\u2019Brien JT (2014) A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review. Int J Geriatr Psychiatry 29:551\u2013561. https:\/\/doi.org\/10.1002\/gps.4036","journal-title":"Int J Geriatr Psychiatry"},{"key":"1330_CR58","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/WNP.0b013e31817da184","volume":"25","author":"W De Haan","year":"2008","unstructured":"De Haan W, Stam CJ, Jones BF et al (2008) Resting-state oscillatory brain dynamics in Alzheimer disease. J Clin Neurophysiol 25:187\u2013193. https:\/\/doi.org\/10.1097\/WNP.0b013e31817da184","journal-title":"J Clin Neurophysiol"},{"key":"1330_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0022-510x(97)00131-7","volume":"152","author":"SM de la Monte","year":"1997","unstructured":"de la Monte SM, Sohn YK, Wands JR (1997) Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer\u2019s disease. J Neurol Sci 152:73\u201383. https:\/\/doi.org\/10.1016\/s0022-510x(97)00131-7","journal-title":"J Neurol Sci"},{"key":"1330_CR60","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00259-002-0967-2","volume":"29","author":"MD Devous","year":"2002","unstructured":"Devous MD (2002) Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies. Eur J Nucl Med 29:1685\u20131696. https:\/\/doi.org\/10.1007\/s00259-002-0967-2","journal-title":"Eur J Nucl Med"},{"key":"1330_CR61","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.bbapap.2011.10.001","volume":"1814","author":"F Di Domenico","year":"2011","unstructured":"Di Domenico F, Coccia R, Butterfield DA, Perluigi M (2011) Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limits. Biochim Biophys Acta 1814:1785\u20131795. https:\/\/doi.org\/10.1016\/j.bbapap.2011.10.001","journal-title":"Biochim Biophys Acta"},{"key":"1330_CR62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB et al (2021) Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol 20:484\u2013496. https:\/\/doi.org\/10.1016\/S1474-4422(21)00066-1","journal-title":"Lancet Neurol"},{"key":"1330_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0503-2","volume":"11","author":"WS Eikelboom","year":"2019","unstructured":"Eikelboom WS, Singleton E, Van Den Berg E et al (2019) Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer\u2019s disease: protocol of the BEAT-IT study. Alzheimer\u2019s Res Ther 11:1\u201312. https:\/\/doi.org\/10.1186\/s13195-019-0503-2","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1330_CR64","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00702-006-0575-6","volume":"113","author":"P Eikelenboom","year":"2006","unstructured":"Eikelenboom P, Veerhuis R, Scheper W et al (2006) The significance of neuroinflammation in understanding Alzheimer\u2019s disease. J Neural Transm 113:1685\u20131695. https:\/\/doi.org\/10.1007\/s00702-006-0575-6","journal-title":"J Neural Transm"},{"key":"1330_CR65","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.neurobiolaging.2014.04.034","volume":"36","author":"SF Eskildsen","year":"2015","unstructured":"Eskildsen SF, Coup\u00e9 P, Fonov VS et al (2015) Structural imaging biomarkers of Alzheimer\u2019s disease: predicting disease progression. Neurobiol Aging 36:S23\u2013S31. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.04.034","journal-title":"Neurobiol Aging"},{"key":"1330_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav6221","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M et al (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aav6221","journal-title":"Sci Transl Med"},{"key":"1330_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/chin.199005359","author":"JB Fenn","year":"1990","unstructured":"Fenn JB, Mann M, Meng CK et al (1990) ChemInform abstract: electrospray ionization for mass spectrometry of large biomolecules. ChemInform. https:\/\/doi.org\/10.1002\/chin.199005359","journal-title":"ChemInform"},{"key":"1330_CR68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00002093-200607000-00006","volume":"20","author":"A Fern\u00e1ndez","year":"2006","unstructured":"Fern\u00e1ndez A, Hornero R, Mayo A et al (2006) Quantitative magnetoencephalography of spontaneous brain activity in Alzheimer disease: an exhaustive frequency analysis. Alzheimer Dis Assoc Disord 20:153\u2013159. https:\/\/doi.org\/10.1097\/00002093-200607000-00006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1330_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.629442","volume":"12","author":"R Ferrando","year":"2021","unstructured":"Ferrando R, Damian A (2021) Brain SPECT as a biomarker of neurodegeneration in dementia in the era of molecular imaging: still a valid option? Front Neurol 12:1\u201316. https:\/\/doi.org\/10.3389\/fneur.2021.629442","journal-title":"Front Neurol"},{"key":"1330_CR70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E et al (2018) Sex differences in Alzheimer disease: the gateway to precision medicine. Nat Rev Neurol 14:457\u2013469. https:\/\/doi.org\/10.1038\/s41582-018-0032-9","journal-title":"Nat Rev Neurol"},{"key":"1330_CR71","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awr038","volume":"134","author":"MT Fodero-Tavoletti","year":"2011","unstructured":"Fodero-Tavoletti MT, Okamura N, Furumoto S et al (2011) 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer\u2019s disease. Brain 134:1089\u20131100. https:\/\/doi.org\/10.1093\/brain\/awr038","journal-title":"Brain"},{"key":"1330_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni GB, Fox NC, Jack CR et al (2010) The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67\u201377. https:\/\/doi.org\/10.1038\/nrneurol.2009.215","journal-title":"Nat Rev Neurol"},{"key":"1330_CR73","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","volume":"16","author":"GB Frisoni","year":"2017","unstructured":"Frisoni GB, Boccardi M, Barkhof F et al (2017) Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers. Lancet Neurol 16:661\u2013676. https:\/\/doi.org\/10.1016\/S1474-4422(17)30159-X","journal-title":"Lancet Neurol"},{"key":"1330_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.150","author":"S Frost","year":"2013","unstructured":"Frost S, Kanagasingam Y, Sohrabi H et al (2013) Retinal vascular biomarkers for early detection and monitoring of Alzheimer\u2019s disease. Transl Psychiatry. https:\/\/doi.org\/10.1038\/tp.2012.150","journal-title":"Transl Psychiatry"},{"key":"1330_CR75","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s12031-014-0356-x","volume":"54","author":"Y Fu","year":"2014","unstructured":"Fu Y, Zhao D, Yang L (2014) Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer\u2019s disease. J Mol Neurosci 54:739\u2013747. https:\/\/doi.org\/10.1007\/s12031-014-0356-x","journal-title":"J Mol Neurosci"},{"key":"1330_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03063-y","author":"I Genovese","year":"2020","unstructured":"Genovese I, Giamogante F, Barazzuol L et al (2020) Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-020-03063-y","journal-title":"Cell Death Dis"},{"key":"1330_CR77","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s40520-016-0637-z","volume":"29","author":"F Guerriero","year":"2017","unstructured":"Guerriero F, Sgarlata C, Francis M et al (2017) Neuroinflammation, immune system and Alzheimer disease: searching for the missing link. Aging Clin Exp Res 29:821\u2013831. https:\/\/doi.org\/10.1007\/s40520-016-0637-z","journal-title":"Aging Clin Exp Res"},{"key":"1330_CR78","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-007-0209-6","volume":"113","author":"AL Guillozet-Bongaarts","year":"2007","unstructured":"Guillozet-Bongaarts AL, Glajch KE, Libson EG et al (2007) Phosphorylation and cleavage of tau in non-AD tauopathies. Acta Neuropathol 113:513\u2013520. https:\/\/doi.org\/10.1007\/s00401-007-0209-6","journal-title":"Acta Neuropathol"},{"key":"1330_CR79","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nrd3115","volume":"9","author":"H Hampel","year":"2010","unstructured":"Hampel H, Frank R, Broich K et al (2010) Biomarkers for alzheimer\u2019s disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov 9:560\u2013574. https:\/\/doi.org\/10.1038\/nrd3115","journal-title":"Nat Rev Drug Discov"},{"key":"1330_CR80","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jalz.2012.05.2116","volume":"8","author":"H Hampel","year":"2012","unstructured":"Hampel H, Lista S, Khachaturian ZS (2012) Development of biomarkers to chart all Alzheimer\u2019s disease stages: the royal road to cutting the therapeutic Gordian Knot. Alzheimer\u2019s Dement 8:312\u2013336","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR81","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel H, O\u2019Bryant SE, Molinuevo JL et al (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 14:639\u2013652. https:\/\/doi.org\/10.1038\/s41582-018-0079-7","journal-title":"Nat Rev Neurol"},{"key":"1330_CR82","first-page":"1","volume":"3","author":"H Hampel","year":"2020","unstructured":"Hampel H, Lista S, Vanmechelen E et al (2020) \u03b2 -Secretase1 biological markers for Alzheimer\u2019s disease: state-of-art of validation and qualification. Alzheimer\u2019s Dis 3:1\u201314","journal-title":"Alzheimer\u2019s Dis"},{"key":"1330_CR83","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","volume":"17","author":"H Hampel","year":"2021","unstructured":"Hampel H, Cummings J, Blennow K et al (2021a) Developing the ATX(N) classification for use across the Alzheimer disease continuum. Nat Rev Neurol 17:580\u2013589. https:\/\/doi.org\/10.1038\/s41582-021-00520-w","journal-title":"Nat Rev Neurol"},{"key":"1330_CR84","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B et al (2021b) The \u03b2-secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry 89:745\u2013756. https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.001","journal-title":"Biol Psychiatry"},{"key":"1330_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021643","author":"X Han","year":"2011","unstructured":"Han X, Rozen S, Boyle SH et al (2011) Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0021643","journal-title":"PLoS ONE"},{"key":"1330_CR86","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","volume":"15","author":"DP Hanger","year":"2009","unstructured":"Hanger DP, Anderton BH, Noble W (2009) Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol Med 15:112\u2013119. https:\/\/doi.org\/10.1016\/j.molmed.2009.01.003","journal-title":"Trends Mol Med"},{"key":"1330_CR87","doi-asserted-by":"publisher","first-page":"103565","DOI":"10.1016\/j.critrevonc.2021.103565","volume":"169","author":"NA Hanjani","year":"2022","unstructured":"Hanjani NA, Esmaelizad N, Zanganeh S et al (2022) Emerging role of exosomes as biomarkers in cancer treatment and diagnosis. Crit Rev Oncol Hematol 169:103565. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103565","journal-title":"Crit Rev Oncol Hematol"},{"key":"1330_CR88","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27:954\u2013963. https:\/\/doi.org\/10.1038\/s41591-021-01382-x","journal-title":"Nat Med"},{"key":"1330_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-019-0485-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, Lehmann S, Otto M et al (2019) Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease. Alzheimer\u2019s Res Ther 11:1\u201315. https:\/\/doi.org\/10.1186\/s13195-019-0485-0","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1330_CR90","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science 297:353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994","journal-title":"Science"},{"key":"1330_CR91","doi-asserted-by":"publisher","first-page":"e036990","DOI":"10.1136\/bmjopen-2020-036990","volume":"10","author":"MF He","year":"2020","unstructured":"He MF, Sun L, Cao W et al (2020) Association between plasma exosome neurogranin and brain structure in patients with Alzheimer\u2019s disease: a protocol study. BMJ Open 10:e036990. https:\/\/doi.org\/10.1136\/bmjopen-2020-036990","journal-title":"BMJ Open"},{"key":"1330_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2019.00904","volume":"10","author":"SH Hojjati","year":"2019","unstructured":"Hojjati SH, Ebrahimzadeh A, Babajani-Feremi A (2019) Identification of the early stage of alzheimer\u2019s disease using structural mri and resting-state fmri. Front Neurol 10:1\u201312. https:\/\/doi.org\/10.3389\/fneur.2019.00904","journal-title":"Front Neurol"},{"key":"1330_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2020.00038","volume":"13","author":"S Hornung","year":"2020","unstructured":"Hornung S, Dutta S, Bitan G (2020) CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci 13:1\u201316. https:\/\/doi.org\/10.3389\/fnmol.2020.00038","journal-title":"Front Mol Neurosci"},{"key":"1330_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-24220-7","volume":"12","author":"WT Hu","year":"2021","unstructured":"Hu WT, Ozturk T, Kollhoff A et al (2021) Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer\u2019s disease. Nat Commun 12:1\u201312. https:\/\/doi.org\/10.1038\/s41467-021-24220-7","journal-title":"Nat Commun"},{"key":"1330_CR95","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.90015","author":"A Husseen Al-Nuaimi","year":"2020","unstructured":"Husseen Al-Nuaimi A, Al-Juboori S, Jammeh E et al (2020) Electroencephalogram based biomarkers for detection of Alzheimer\u2019s disease. Neuroimaging. https:\/\/doi.org\/10.5772\/intechopen.90015","journal-title":"Neuroimaging"},{"key":"1330_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 8:1\u201313. https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR97","volume-title":"Early diagnosis of neurodegenerative diseases from gait discrimination to neural synchronization","author":"S Iram","year":"2015","unstructured":"Iram S, Vialatte FB, Qamar MI (2015) Early diagnosis of neurodegenerative diseases from gait discrimination to neural synchronization. Elsevier Inc, Amsterdam"},{"key":"1330_CR98","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jnc.13399","volume":"136","author":"A Ishiki","year":"2016","unstructured":"Ishiki A, Kamada M, Kawamura Y et al (2016) Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration. J Neurochem 136:258\u2013261","journal-title":"J Neurochem"},{"key":"1330_CR99","first-page":"1","volume":"1","author":"CR Jack","year":"2016","unstructured":"Jack CR, Hampel HJ, Universities S et al (2016) A new classification system for AD, independent of cognition A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 1:1\u201310","journal-title":"Neurology"},{"key":"1330_CR100","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR101","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","volume":"19","author":"W Jagust","year":"2018","unstructured":"Jagust W (2018) Imaging the evolution and pathophysiology of Alzheimer disease. Nat Rev Neurosci 19:687\u2013700. https:\/\/doi.org\/10.1038\/s41583-018-0067-3","journal-title":"Nat Rev Neurosci"},{"key":"1330_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0579-2","author":"G Jain","year":"2019","unstructured":"Jain G, Stuendl A, Rao P et al (2019) A combined miRNA\u2013piRNA signature to detect Alzheimer\u2019s disease. Transl Psychiatry. https:\/\/doi.org\/10.1038\/s41398-019-0579-2","journal-title":"Transl Psychiatry"},{"key":"1330_CR103","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/acn3.266","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Hertze J, Zetterberg H et al (2016a) Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer\u2019s disease. Ann Clin Transl Neurol 3:12\u201320. https:\/\/doi.org\/10.1002\/acn3.266","journal-title":"Ann Clin Transl Neurol"},{"key":"1330_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26801","volume":"6","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Stomrud E, Palmqvist S et al (2016b) Plasma \u03b2-amyloid in Alzheimer\u2019s disease and vascular disease. Sci Rep 6:1\u201311. https:\/\/doi.org\/10.1038\/srep26801","journal-title":"Sci Rep"},{"key":"1330_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15436-0","volume":"11","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Stomrud E, Smith R et al (2020) Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease. Nat Commun 11:1\u201312. https:\/\/doi.org\/10.1038\/s41467-020-15436-0","journal-title":"Nat Commun"},{"key":"1330_CR106","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Teunissen CE, Zetterberg H et al (2021) Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease. JAMA Neurol 78:1375\u20131382. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3180","journal-title":"JAMA Neurol"},{"key":"1330_CR107","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41588-019-0573-x","volume":"52","author":"IE Jansen","year":"2020","unstructured":"Jansen IE, Savage JE, Watanabe K et al (2020) Author Correction: genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet 52:354. https:\/\/doi.org\/10.1038\/s41588-019-0573-x","journal-title":"Nat Genet"},{"key":"1330_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/alz.12166","volume":"17","author":"L Jia","year":"2021","unstructured":"Jia L, Zhu M, Kong C et al (2021) Blood neuro-exosomal synaptic proteins predict Alzheimer\u2019s disease at the asymptomatic stage. Alzheimer\u2019s Dement 17:49\u201360. https:\/\/doi.org\/10.1002\/alz.12166","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR109","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.12659\/MSM.914027","volume":"25","author":"L Jiang","year":"2019","unstructured":"Jiang L, Dong H, Cao H et al (2019) Exosomes in pathogenesis, diagnosis, and treatment of alzheimer\u2019s disease. Med Sci Monit 25:3329\u20133335. https:\/\/doi.org\/10.12659\/MSM.914027","journal-title":"Med Sci Monit"},{"key":"1330_CR110","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","volume":"283","author":"K Jomova","year":"2011","unstructured":"Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283:65\u201387","journal-title":"Toxicology"},{"key":"1330_CR111","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R, Rozen S, Matson W et al (2011) Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7:309\u2013317. https:\/\/doi.org\/10.1016\/j.jalz.2010.06.001","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR112","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/alz.12236","volume":"17","author":"TK Karikari","year":"2021","unstructured":"Karikari TK, Emer\u0161i\u010d A, Vrillon A et al (2021) Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer\u2019s disease diagnosis. Alzheimer\u2019s Dement 17:755\u2013767. https:\/\/doi.org\/10.1002\/alz.12236","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR113","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-03164-z","author":"P Kaur","year":"2022","unstructured":"Kaur P, Khera A, Alajangi HK et al (2022) Role of tau in various tauopathies, treatment approaches, and emerging role of nanotechnology in neurodegenerative disorders. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-022-03164-z","journal-title":"Mol Neurobiol"},{"key":"1330_CR114","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1074\/mcp.R120.002234","volume":"19","author":"RT Kelly","year":"2020","unstructured":"Kelly RT (2020) Single-cell proteomics: progress and prospects. Mol Cell Proteomics 19:1739\u20131748. https:\/\/doi.org\/10.1074\/mcp.R120.002234","journal-title":"Mol Cell Proteomics"},{"key":"1330_CR115","first-page":"5193","volume":"112","author":"KP Kepp","year":"2012","unstructured":"Kepp KP (2012) Bioinorganic chemistry of Alzheimer \u2019 s disease. Bioorg Chem 112:5193","journal-title":"Bioorg Chem"},{"key":"1330_CR116","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577\u2013589. https:\/\/doi.org\/10.1038\/s41582-018-0058-z","journal-title":"Nat Rev Neurol"},{"key":"1330_CR117","doi-asserted-by":"publisher","DOI":"10.2174\/1567201819666220404103936","author":"A Khera","year":"2022","unstructured":"Khera A, Alajangi HK, Khajuria A et al (2022) Highlighting the potential role of exosomes as the targeted nanotherapeutic carrier in metastatic breast cancer. Curr Drug Deliv. https:\/\/doi.org\/10.2174\/1567201819666220404103936","journal-title":"Curr Drug Deliv"},{"key":"1330_CR118","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1021\/acssensors.8b01242","volume":"4","author":"H Kim","year":"2019","unstructured":"Kim H, Lee JU, Kim S et al (2019) A nanoplasmonic biosensor for ultrasensitive detection of Alzheimer\u2019s disease biomarker using a chaotropic agent. ACS Sensors 4:595\u2013602. https:\/\/doi.org\/10.1021\/acssensors.8b01242","journal-title":"ACS Sensors"},{"key":"1330_CR119","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/01616412.2017.1281195","volume":"39","author":"Y Kitamura","year":"2017","unstructured":"Kitamura Y, Usami R, Ichihara S et al (2017) Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer\u2019s disease. Neurol Res 39:231\u2013238. https:\/\/doi.org\/10.1080\/01616412.2017.1281195","journal-title":"Neurol Res"},{"key":"1330_CR120","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000505625","volume":"19","author":"J Klohs","year":"2020","unstructured":"Klohs J (2020) An integrated view on vascular dysfunction in Alzheimer\u2019s disease. Neurodegener Dis 19:109\u2013127. https:\/\/doi.org\/10.1159\/000505625","journal-title":"Neurodegener Dis"},{"key":"1330_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC et al (2021) Alzheimer disease. Nat Rev Dis Prim 7:1\u201321. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nat Rev Dis Prim"},{"key":"1330_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI.INSIGHT.93621","volume":"2","author":"Y Koronyo","year":"2017","unstructured":"Koronyo Y, Biggs D, Barron E et al (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight 2:1\u201319. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.93621","journal-title":"JCI Insight"},{"key":"1330_CR123","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1172\/JCI118957","volume":"98","author":"FM LaFerla","year":"1996","unstructured":"LaFerla FM, Hall CK, Ngo L, Jay G (1996) Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J Clin Invest 98:1626\u20131632. https:\/\/doi.org\/10.1172\/JCI118957","journal-title":"J Clin Invest"},{"key":"1330_CR124","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.neurobiolaging.2003.12.024","volume":"25","author":"DK Lahiri","year":"2004","unstructured":"Lahiri DK, Sambamurti K, Bennett DA (2004) Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer\u2019s disease. Neurobiol Aging 25:651\u2013660. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.12.024","journal-title":"Neurobiol Aging"},{"key":"1330_CR125","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5485080","author":"RK Lama","year":"2017","unstructured":"Lama RK, Gwak J, Park JS, Lee SW (2017) Diagnosis of Alzheimer\u2019s disease based on structural MRI images using a regularized extreme learning machine and PCA features. J Healthc Eng. https:\/\/doi.org\/10.1155\/2017\/5485080","journal-title":"J Healthc Eng"},{"key":"1330_CR126","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, European Alzheimer\u2019s Disease I, Genetic, Environmental Risk in Alzheimer\u2019s D, Alzheimer\u2019s Disease Genetic C, Cohorts for H, Aging Research in Genomic E et al (2013a) . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458","journal-title":"Nat Genet"},{"key":"1330_CR127","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013b) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458. https:\/\/doi.org\/10.1038\/ng.2802","journal-title":"Nat Genet"},{"key":"1330_CR128","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2466\/15.17.23.PMS.111.5.485-495","volume":"111","author":"GE Lancioni","year":"2010","unstructured":"Lancioni GE, Singh NN, O\u2019reilly MF et al (2010) Persons with acquired brain injury and multiple disabilities access stimulation independently through microswitch-based technology. Percept Mot Skills 111:485\u2013495. https:\/\/doi.org\/10.2466\/15.17.23.PMS.111.5.485-495","journal-title":"Percept Mot Skills"},{"key":"1330_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.06.003","author":"C Laske","year":"2014","unstructured":"Laske C, Stellos K, Kempter I et al (2014) Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer \u2019 s disease. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2014.06.003","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR130","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jalz.2014.06.004","volume":"11","author":"C Laske","year":"2015","unstructured":"Laske C, Sohrabi HR, Frost SM et al (2015) Innovative diagnostic tools for early detection of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 11:561\u2013578. https:\/\/doi.org\/10.1016\/j.jalz.2014.06.004","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR131","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jamapsychiatry.2014.1060","volume":"71","author":"R Lautner","year":"2014","unstructured":"Lautner R, Palmqvist S, Mattsson N et al (2014) Apolipoprotein e genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for alzheimer disease. JAMA Psychiat 71:1183\u20131191. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1060","journal-title":"JAMA Psychiat"},{"key":"1330_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-019-0250-2","author":"JC Lee","year":"2019","unstructured":"Lee JC, Kim SJ, Hong S, Kim YS (2019) Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers. Exp Mol Med. https:\/\/doi.org\/10.1038\/s12276-019-0250-2","journal-title":"Exp Mol Med"},{"key":"1330_CR133","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/mp.2008.84","volume":"15","author":"P Lewczuk","year":"2010","unstructured":"Lewczuk P, Kamrowski-Kruck H, Peters O et al (2010) Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer\u2019s disease: a multicenter study. Mol Psychiatry 15:138\u2013145. https:\/\/doi.org\/10.1038\/mp.2008.84","journal-title":"Mol Psychiatry"},{"key":"1330_CR134","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/14737175.2016.1204234","volume":"17","author":"S Lista","year":"2017","unstructured":"Lista S, Hampel H (2017) Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer\u2019s disease. Expert Rev Neurother 17:47\u201357. https:\/\/doi.org\/10.1080\/14737175.2016.1204234","journal-title":"Expert Rev Neurother"},{"key":"1330_CR135","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-0801-2","author":"W Liu","year":"2020","unstructured":"Liu W, Lin H, He X et al (2020) Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer\u2019s disease and mild cognitive impairment. Transl Psychiatry. https:\/\/doi.org\/10.1038\/s41398-020-0801-2","journal-title":"Transl Psychiatry"},{"key":"1330_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2018.00572","volume":"12","author":"D L\u00f3pez-Sanz","year":"2018","unstructured":"L\u00f3pez-Sanz D, Serrano N, Maest\u00fa F (2018) The role of magnetoencephalography in the early stages of Alzheimer\u2019s disease. Front Neurosci 12:1\u20138. https:\/\/doi.org\/10.3389\/fnins.2018.00572","journal-title":"Front Neurosci"},{"key":"1330_CR137","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3978\/j.issn.2223-4292.2015.03.16","volume":"5","author":"F-M Lu","year":"2015","unstructured":"Lu F-M, Yuan Z (2015) PET\/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases. Quant Imaging Med Surg 5:433\u2013447. https:\/\/doi.org\/10.3978\/j.issn.2223-4292.2015.03.16","journal-title":"Quant Imaging Med Surg"},{"key":"1330_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22871-z","volume":"8","author":"D Lu","year":"2018","unstructured":"Lu D, Popuri K, Ding GW et al (2018) Multimodal and multiscale deep neural networks for the early diagnosis of Alzheimer\u2019s disease using structural MR and FDG-PET images. Sci Rep 8:1\u201313. https:\/\/doi.org\/10.1038\/s41598-018-22871-z","journal-title":"Sci Rep"},{"key":"1330_CR139","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-160835","volume":"55","author":"TA Lusardi","year":"2017","unstructured":"Lusardi TA, Phillips JI, Wiedrick JT et al (2017) MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 55:1223\u20131233. https:\/\/doi.org\/10.3233\/JAD-160835","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR140","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/606802","author":"SK Maji","year":"2010","unstructured":"Maji SK, Anoop A, Singh PK, Jacob RS (2010) CSF biomarkers for Alzheimer\u2019s disease diagnosis. Int J Alzheimers Dis. https:\/\/doi.org\/10.4061\/2010\/606802","journal-title":"Int J Alzheimers Dis"},{"key":"1330_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fncom.2018.00060","author":"PK Mandal","year":"2018","unstructured":"Mandal PK, Banerjee A, Tripathi M, Sharma A (2018) A comprehensive review of magnetoencephalography (MEG) studies for brain functionality in healthy aging and Alzheimer\u2019s disease (AD). Front Comput Neurosci. https:\/\/doi.org\/10.3389\/fncom.2018.00060","journal-title":"Front Comput Neurosci"},{"key":"1330_CR142","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/sim.1718","volume":"23","author":"RB Mani","year":"2004","unstructured":"Mani RB (2004) The evaluation of disease modifying therapies in Alzheimer\u2019s disease: a regulatory viewpoint. Stat Med 23:305\u2013314. https:\/\/doi.org\/10.1002\/sim.1718","journal-title":"Stat Med"},{"key":"1330_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph13090243","volume":"13","author":"I Manna","year":"2020","unstructured":"Manna I, de Benedittis S, Quattrone A et al (2020) Exosomal miRNAs as potential diagnostic biomarkers in Alzheimer\u2019s disease. Pharmaceuticals 13:1\u201316. https:\/\/doi.org\/10.3390\/ph13090243","journal-title":"Pharmaceuticals"},{"key":"1330_CR144","doi-asserted-by":"publisher","first-page":"127163","DOI":"10.1016\/j.foodchem.2020.127163","volume":"331","author":"M Mansouri","year":"2020","unstructured":"Mansouri M, Fathi F, Jalili R et al (2020) SPR enhanced DNA biosensor for sensitive detection of donkey meat adulteration. Food Chem 331:127163. https:\/\/doi.org\/10.1016\/j.foodchem.2020.127163","journal-title":"Food Chem"},{"key":"1330_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-018-0150-6","volume":"8","author":"RE Marioni","year":"2018","unstructured":"Marioni RE, Harris SE, Zhang Q et al (2018) GWAS on family history of Alzheimer\u2019s disease. Transl Psychiatry 8:1\u20136. https:\/\/doi.org\/10.1038\/s41398-018-0150-6","journal-title":"Transl Psychiatry"},{"key":"1330_CR146","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41592-019-0540-6","volume":"16","author":"V Marx","year":"2019","unstructured":"Marx V (2019) A dream of single-cell proteomics. Nat Methods 16:809\u2013812. https:\/\/doi.org\/10.1038\/s41592-019-0540-6","journal-title":"Nat Methods"},{"key":"1330_CR147","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1749-6632.1999.tb07824.x","volume":"893","author":"MP Mattson","year":"1999","unstructured":"Mattson MP, Pedersen WA, Duan W et al (1999) Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer\u2019s and Parkinson\u2019s diseases. Ann N Y Acad Sci 893:154\u2013175. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb07824.x","journal-title":"Ann N Y Acad Sci"},{"key":"1330_CR148","doi-asserted-by":"publisher","DOI":"10.1042\/bss0670151","author":"MP Mattson","year":"2001","unstructured":"Mattson MP, Gary DS, Chan SL, Duan W (2001) Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer\u2019s disease. Biochem Soc Symp. https:\/\/doi.org\/10.1042\/bss0670151","journal-title":"Biochem Soc Symp"},{"key":"1330_CR149","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H et al (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 74:557\u2013566. https:\/\/doi.org\/10.1001\/jamaneurol.2016.6117","journal-title":"JAMA Neurol"},{"key":"1330_CR150","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U et al (2019) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol 76:791\u2013799. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0765","journal-title":"JAMA Neurol"},{"key":"1330_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19957-6","volume":"11","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Palmqvist S, Blennow K, Hansson O (2020) Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies. Nat Commun 11:1\u201311. https:\/\/doi.org\/10.1038\/s41467-020-19957-6","journal-title":"Nat Commun"},{"key":"1330_CR152","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00436","author":"CD Mayo","year":"2019","unstructured":"Mayo CD, Garcia-Barrera MA, Mazerolle EL et al (2019) Relationship between DTI metrics and cognitive function in Alzheimer\u2019s disease. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2018.00436","journal-title":"Front Aging Neurosci"},{"key":"1330_CR153","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1586\/ern.10.162","volume":"10","author":"LK McEvoy","year":"2010","unstructured":"McEvoy LK, Brewer JB (2010) Quantitative structural MRI for early detection of Alzheimers disease. Expert Rev Neurother 10:1675\u20131688. https:\/\/doi.org\/10.1586\/ern.10.162","journal-title":"Expert Rev Neurother"},{"key":"1330_CR154","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7:263\u2013269","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR155","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.trci.2017.08.009","volume":"3","author":"M Medina","year":"2017","unstructured":"Medina M, Khachaturian ZS, Rossor M et al (2017) Toward common mechanisms for risk factors in Alzheimer\u2019s syndrome. Alzheimer\u2019s Dement Transl Res Clin Interv 3:571\u2013578. https:\/\/doi.org\/10.1016\/j.trci.2017.08.009","journal-title":"Alzheimer\u2019s Dement Transl Res Clin Interv"},{"key":"1330_CR156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2022.911220","volume":"14","author":"X Meng","year":"2022","unstructured":"Meng X, Liu J, Fan X et al (2022) Multi-modal neuroimaging neural network-based feature detection for diagnosis of Alzheimer\u2019 s disease. Front. Age Ageing 14:1\u201311. https:\/\/doi.org\/10.3389\/fnagi.2022.911220","journal-title":"Front. Age Ageing"},{"key":"1330_CR157","doi-asserted-by":"publisher","first-page":"85","DOI":"10.24875\/RIC.18002754","volume":"71","author":"DE Meza-S\u00e1nchez","year":"2019","unstructured":"Meza-S\u00e1nchez DE, Maravillas-Montero JL (2019) Clinical and biomedical applications of surface plasmon resonance systems. Rev Investig Clin 71:85\u201390. https:\/\/doi.org\/10.24875\/RIC.18002754","journal-title":"Rev Investig Clin"},{"key":"1330_CR158","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/09540260600583007","volume":"18","author":"MM Mielke","year":"2006","unstructured":"Mielke MM, Lyketsos CG (2006) Lipids and the pathogenesis of Alzheimer\u2019s disease: is there a link? Int Rev Psychiatry 18:173\u2013186. https:\/\/doi.org\/10.1080\/09540260600583007","journal-title":"Int Rev Psychiatry"},{"key":"1330_CR159","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1515\/revneuro-2016-0029","volume":"27","author":"G Mirzaei","year":"2016","unstructured":"Mirzaei G, Adeli A, Adeli H (2016) Imaging and machine learning techniques for diagnosis of Alzheimer\u2019s disease. Rev Neurosci 27:857\u2013870. https:\/\/doi.org\/10.1515\/revneuro-2016-0029","journal-title":"Rev Neurosci"},{"key":"1330_CR160","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1093\/gerona\/60.5.660","volume":"60","author":"P Missonnier","year":"2005","unstructured":"Missonnier P, Gold G, Fazio-Costa L et al (2005) Early event-related potential changes during working memory activation predict rapid decline in mild cognitive impairment. J Gerontol Ser A 60:660\u2013666","journal-title":"J Gerontol Ser A"},{"key":"1330_CR161","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1932-x","volume-title":"Current state of Alzheimer\u2019s fluid biomarkers","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL, Ayton S, Batrla R et al (2018) Current state of Alzheimer\u2019s fluid biomarkers. Springer, Berlin Heidelberg"},{"key":"1330_CR162","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME (2021) Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: a clinicopathologic perspective for biomarker research. Alzheimer\u2019s Dement 17:1554\u20131574. https:\/\/doi.org\/10.1002\/alz.12321","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR163","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.410380413","volume":"38","author":"R Motter","year":"1995","unstructured":"Motter R, Vigo-Pelfrey C, Kholodenko D et al (1995) Reduction of \u03b2-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer\u2019s disease. Ann Neurol 38:643\u2013648. https:\/\/doi.org\/10.1002\/ana.410380413","journal-title":"Ann Neurol"},{"key":"1330_CR164","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3233\/JAD-2005-8406","volume":"8","author":"RE Mrak","year":"2005","unstructured":"Mrak RE, Griffin WST (2005) Potential inflammatory biomarkers in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 8:369\u2013375","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR165","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neurobiolaging.2013.07.005","volume":"35","author":"M M\u00fcller","year":"2014","unstructured":"M\u00fcller M, Kuiperij HB, Claassen JA et al (2014) MicroRNAs in Alzheimer\u2019s disease: differential expression in hippocampus and cell-free cerebrospinal fluid. Neurobiol Aging 35:152\u2013158. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.07.005","journal-title":"Neurobiol Aging"},{"key":"1330_CR166","doi-asserted-by":"publisher","first-page":"12606","DOI":"10.1021\/bi050926p","volume":"44","author":"IVJ Murray","year":"2005","unstructured":"Murray IVJ, Sindoni ME, Axelsen PH (2005) Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochemistry 44:12606\u201312613. https:\/\/doi.org\/10.1021\/bi050926p","journal-title":"Biochemistry"},{"key":"1330_CR167","first-page":"331","volume":"25","author":"J Mutter","year":"2004","unstructured":"Mutter J, Naumann J, Sadaghiani C et al (2004) Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuroendocrinol Lett 25:331\u2013339","journal-title":"Neuroendocrinol Lett"},{"key":"1330_CR168","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL et al (2018) High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature 554:249\u2013254. https:\/\/doi.org\/10.1038\/nature25456","journal-title":"Nature"},{"key":"1330_CR169","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev.med.55.091902.103653","volume":"55","author":"H Needleman","year":"2004","unstructured":"Needleman H (2004) Lead poisoning. Annu Rev Med 55:209\u2013222","journal-title":"Annu Rev Med"},{"key":"1330_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00604-019-3903-x","volume":"186","author":"M Negahdary","year":"2019","unstructured":"Negahdary M, Heli H (2019) An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-\u03b2(1\u201342) using a microporous gold nanostructure. Microchim Acta 186:1\u20138. https:\/\/doi.org\/10.1007\/s00604-019-3903-x","journal-title":"Microchim Acta"},{"key":"1330_CR171","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.tins.2022.02.005","volume":"45","author":"SM Neuner","year":"2022","unstructured":"Neuner SM, Telpoukhovskaia M, Menon V et al (2022) Translational approaches to understanding resilience to Alzheimer\u2019s disease. Trends Neurosci 45:369\u2013383. https:\/\/doi.org\/10.1016\/j.tins.2022.02.005","journal-title":"Trends Neurosci"},{"key":"1330_CR172","doi-asserted-by":"publisher","first-page":"239821281990108","DOI":"10.1177\/2398212819901082","volume":"4","author":"C N\u00ed Chasaide","year":"2020","unstructured":"N\u00ed Chasaide C, Lynch MA (2020) The role of the immune system in driving neuroinflammation. Brain Neurosci Adv 4:239821281990108. https:\/\/doi.org\/10.1177\/2398212819901082","journal-title":"Brain Neurosci Adv"},{"key":"1330_CR173","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-319-52479-5","volume":"974","author":"EV N\u00fa\u00f1ez","year":"2017","unstructured":"N\u00fa\u00f1ez EV, Guest PC, Martins-de-souza D (2017) Proteomic methods in neuropsychiatric research. Adv Exp Med Biol 974:219\u2013227. https:\/\/doi.org\/10.1007\/978-3-319-52479-5","journal-title":"Adv Exp Med Biol"},{"key":"1330_CR174","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-180325","volume":"67","author":"P Oeckl","year":"2019","unstructured":"Oeckl P, Halbgebauer S, Anderl-Straub S et al (2019) Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment. J Alzheimer\u2019s Dis 67:481\u2013488. https:\/\/doi.org\/10.3233\/JAD-180325","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR175","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-016-0208-8","volume":"8","author":"A \u00d6hrfelt","year":"2016","unstructured":"\u00d6hrfelt A, Brinkmalm A, Dumurgier J et al (2016) The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 8:1\u201310. https:\/\/doi.org\/10.1186\/s13195-016-0208-8","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1330_CR176","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0500-6","author":"N Okamura","year":"2014","unstructured":"Okamura N, Harada R, Furumoto S et al (2014) Tau PET imaging in Alzheimer\u2019s disease. Curr Neurol Neurosci Rep. https:\/\/doi.org\/10.1007\/s11910-014-0500-6","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1330_CR177","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cca.2011.01.003","volume":"412","author":"K Okumura","year":"2011","unstructured":"Okumura K, Tsukamoto H (2011) Folate in smokers. Clin Chim Acta 412:521\u2013526","journal-title":"Clin Chim Acta"},{"key":"1330_CR178","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U et al (2016) CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol 15:673\u2013684. https:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3","journal-title":"Lancet Neurol"},{"key":"1330_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm10030063","volume":"10","author":"SH Omar","year":"2020","unstructured":"Omar SH, Preddy J (2020) Advantages and pitfalls in fluid biomarkers for diagnosis of Alzheimer\u2019s disease. J Pers Med 10:1\u201320. https:\/\/doi.org\/10.3390\/jpm10030063","journal-title":"J Pers Med"},{"key":"1330_CR180","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1046\/j.1471-4159.1994.62052049.x","volume":"62","author":"P Palkiewicz","year":"1994","unstructured":"Palkiewicz P, Zwiers H, Lorscheider FL (1994) ADP-Ribosylation of brain neuronal proteins is altered by in vitro and in vivo exposure to inorganic mercury. J Neurochem 62:2049\u20132052","journal-title":"J Neurochem"},{"key":"1330_CR181","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","volume":"76","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Janelidze S, Stomrud E et al (2019) Performance of fully automated plasma assays as screening tests for alzheimer disease-related \u03b2-amyloid status. JAMA Neurol 76:1060\u20131069. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1632","journal-title":"JAMA Neurol"},{"key":"1330_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-017-0248-8","volume":"9","author":"JC Park","year":"2017","unstructured":"Park JC, Han SH, Cho HJ et al (2017) Chemically treated plasma A\u03b2 is a potential blood-based biomarker for screening cerebral amyloid deposition. Alzheimer\u2019s Res Ther 9:1\u201313. https:\/\/doi.org\/10.1186\/s13195-017-0248-8","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1330_CR183","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5483\/BMBRep.2020.53.1.309","volume":"53","author":"JC Park","year":"2020","unstructured":"Park JC, Han SH, Mook-Jung I (2020a) Peripheral inflammatory biomarkers in Alzheimer\u2019s disease: a brief review. BMB Rep 53:10\u201319. https:\/\/doi.org\/10.5483\/BMBRep.2020.53.1.309","journal-title":"BMB Rep"},{"key":"1330_CR184","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s12276-020-0418-9","volume":"52","author":"SA Park","year":"2020","unstructured":"Park SA, Han SM, Kim CE (2020b) New fluid biomarkers tracking non-amyloid-\u03b2 and non-tau pathology in Alzheimer\u2019s disease. Exp Mol Med 52:556\u2013568. https:\/\/doi.org\/10.1038\/s12276-020-0418-9","journal-title":"Exp Mol Med"},{"key":"1330_CR185","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12078-015-9198-3","volume":"8","author":"GC Passali","year":"2015","unstructured":"Passali GC, Politi L, Crisanti A et al (2015) Tau protein detection in anosmic Alzheimer\u2019s disease patient\u2019s nasal secretions. Chemosens Percept 8:201\u2013206. https:\/\/doi.org\/10.1007\/s12078-015-9198-3","journal-title":"Chemosens Percept"},{"key":"1330_CR186","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/1567205014666170111145817","volume":"14","author":"A Pedrinolla","year":"2017","unstructured":"Pedrinolla A, Schena F, Venturelli M (2017) Resilience to Alzheimer\u2019s disease: the role of physical activity. Curr Alzheimer Res 14:546\u2013553. https:\/\/doi.org\/10.2174\/1567205014666170111145817","journal-title":"Curr Alzheimer Res"},{"key":"1330_CR187","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.freeradbiomed.2018.06.038","volume":"124","author":"C Pe\u00f1a-Bautista","year":"2018","unstructured":"Pe\u00f1a-Bautista C, Vigor C, Galano JM et al (2018) Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection. Free Radic Biol Med 124:388\u2013394. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.038","journal-title":"Free Radic Biol Med"},{"key":"1330_CR188","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cca.2019.01.021","volume":"491","author":"C Pe\u00f1a-Bautista","year":"2019","unstructured":"Pe\u00f1a-Bautista C, Baquero M, Vento M, Ch\u00e1fer-Peric\u00e1s C (2019a) Free radicals in Alzheimer\u2019s disease: lipid peroxidation biomarkers. Clin Chim Acta 491:85\u201390. https:\/\/doi.org\/10.1016\/j.cca.2019.01.021","journal-title":"Clin Chim Acta"},{"key":"1330_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50837-2","volume":"9","author":"C Pe\u00f1a-Bautista","year":"2019","unstructured":"Pe\u00f1a-Bautista C, Vigor C, Galano JM et al (2019b) New screening approach for Alzheimer\u2019s disease risk assessment from urine lipid peroxidation compounds. Sci Rep 9:1\u20138. https:\/\/doi.org\/10.1038\/s41598-019-50837-2","journal-title":"Sci Rep"},{"key":"1330_CR190","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jalz.2012.05.638","volume":"8","author":"V P\u00e9rez","year":"2012","unstructured":"P\u00e9rez V, Sarasa L, Allue JA et al (2012) O2\u201303-05: beta-amyloid-17 is a major beta-amyloid fragment isoform in cerebrospinal fluid and blood that shows diagnostic value. Alzheimer\u2019s Dement 8:240. https:\/\/doi.org\/10.1016\/j.jalz.2012.05.638","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR191","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3233\/JAD-201455","volume":"80","author":"E Perez-Valero","year":"2021","unstructured":"Perez-Valero E, Lopez-Gordo MA, Morillas C et al (2021) A review of automated techniques for assisting the early detection of Alzheimer\u2019s disease with a focus on EEG. J Alzheimer\u2019s Dis 80:1363\u20131376. https:\/\/doi.org\/10.3233\/JAD-201455","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.11","author":"R Perneczky","year":"2013","unstructured":"Perneczky R, Guo LH, Kagerbauer SM et al (2013) Soluble amyloid precursor protein \u03b2 as blood-based biomarker of Alzheimer\u2019s disease. Transl Psychiatry. https:\/\/doi.org\/10.1038\/tp.2013.11","journal-title":"Transl Psychiatry"},{"key":"1330_CR193","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","volume":"233","author":"A Petzold","year":"2005","unstructured":"Petzold A (2005) Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 233:183\u2013198. https:\/\/doi.org\/10.1016\/j.jns.2005.03.015","journal-title":"J Neurol Sci"},{"key":"1330_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01202-3","author":"L Piubelli","year":"2021","unstructured":"Piubelli L, Pollegioni L, Rabattoni V et al (2021) Serum d-serine levels are altered in early phases of Alzheimer\u2019s disease: towards a precocious biomarker. Transl Psychiatry. https:\/\/doi.org\/10.1038\/s41398-021-01202-3","journal-title":"Transl Psychiatry"},{"key":"1330_CR195","doi-asserted-by":"publisher","DOI":"10.1109\/IEMBS.2007.4353766","author":"J Poza","year":"2007","unstructured":"Poza J, Hornero R, Abas\u00f3lo D et al (2007) Analysis of spontaneous MEG activity in patients with Alzheimer\u2019s disease using spectral entropies. Annu Int Conf IEEE Eng Med Biol. https:\/\/doi.org\/10.1109\/IEMBS.2007.4353766","journal-title":"Annu Int Conf IEEE Eng Med Biol"},{"key":"1330_CR196","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.bbalip.2010.01.009","volume":"1801","author":"D Pratic\u00f2","year":"2010","unstructured":"Pratic\u00f2 D (2010) The neurobiology of isoprostanes and Alzheimer\u2019s disease. Biochim Biophys Acta 1801:930\u2013933. https:\/\/doi.org\/10.1016\/j.bbalip.2010.01.009","journal-title":"Biochim Biophys Acta"},{"key":"1330_CR197","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2174\/1389203721666200511094222","volume":"21","author":"N Puranik","year":"2020","unstructured":"Puranik N, Yadav D, Yadav SK et al (2020) Proteomics and neurodegenerative disorders: advancements in the diagnostic analysis. Curr Protein Pept Sci 21:1174\u20131183. https:\/\/doi.org\/10.2174\/1389203721666200511094222","journal-title":"Curr Protein Pept Sci"},{"key":"1330_CR198","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.11591\/ijeecs.v25.i3.pp1420-1428","volume":"25","author":"D Puri","year":"2022","unstructured":"Puri D, Nalbalwar S, Nandgaonkar A, Wagh A (2022) Alzheimer\u2019s disease detection from optimal electroencephalogram channels and tunable Q-wavelet transform. Indones J Electr Eng Comput Sci 25:1420\u20131428. https:\/\/doi.org\/10.11591\/ijeecs.v25.i3.pp1420-1428","journal-title":"Indones J Electr Eng Comput Sci"},{"key":"1330_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80164-w","volume":"11","author":"MO Quartey","year":"2021","unstructured":"Quartey MO, Nyarko JNK, Maley JM et al (2021) The A\u03b2(1\u201338) peptide is a negative regulator of the A\u03b2(1\u201342) peptide implicated in Alzheimer disease progression. Sci Rep 11:1\u201317. https:\/\/doi.org\/10.1038\/s41598-020-80164-w","journal-title":"Sci Rep"},{"key":"1330_CR200","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.nicl.2014.07.006","volume":"5","author":"KG Ranasinghe","year":"2014","unstructured":"Ranasinghe KG, Hinkley LB, Beagle AJ et al (2014) Regional functional connectivity predicts distinct cognitive impairments in Alzheimer\u2019s disease spectrum. NeuroImage Clin 5:385\u2013395. https:\/\/doi.org\/10.1016\/j.nicl.2014.07.006","journal-title":"NeuroImage Clin"},{"key":"1330_CR201","doi-asserted-by":"publisher","first-page":"712","DOI":"10.2174\/1567205012666150701103107","volume":"12","author":"J Raskin","year":"2015","unstructured":"Raskin J, Cummings J, Hardy J et al (2015) Neurobiology of Alzheimer\u2019s disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr Alzheimer Res 12:712\u2013722. https:\/\/doi.org\/10.2174\/1567205012666150701103107","journal-title":"Curr Alzheimer Res"},{"key":"1330_CR202","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/dnnd.s228939","volume":"9","author":"J Rasmussen","year":"2019","unstructured":"Rasmussen J, Langerman H (2019) Alzheimer\u2019s Disease: why we need early diagnosis. Degener Neurol Neuromuscul Dis 9:123\u2013130. https:\/\/doi.org\/10.2147\/dnnd.s228939","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"1330_CR203","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22010440","volume":"22","author":"S Rastogi","year":"2021","unstructured":"Rastogi S, Sharma V, Bharti PS et al (2021) The evolving landscape of exosomes in neurodegenerative diseases: exosomes characteristics and a promising role in early diagnosis. Int J Mol Sci 22:1\u201331. https:\/\/doi.org\/10.3390\/ijms22010440","journal-title":"Int J Mol Sci"},{"key":"1330_CR204","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1021\/pr500880b","volume":"13","author":"N Rauniyar","year":"2014","unstructured":"Rauniyar N, Yates JR (2014) Isobaric labeling-based relative quanti fi cation in shotgun proteomics. J Proteome Res 13:5293\u20135309","journal-title":"J Proteome Res"},{"key":"1330_CR205","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C et al (2007) Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat Med 13:1359\u20131362. https:\/\/doi.org\/10.1038\/nm1653","journal-title":"Nat Med"},{"key":"1330_CR206","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3233\/JAD-131373","volume":"39","author":"J Reinert","year":"2014","unstructured":"Reinert J, Martens H, Huettenrauch M et al (2014) A\u03b2 38 in the brains of patients with sporadic and familial Alzheimer\u2019s disease and transgenic mouse models. J Alzheimer\u2019s Dis 39:871\u2013881","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR207","doi-asserted-by":"publisher","first-page":"112511","DOI":"10.1016\/j.bios.2020.112511","volume":"167","author":"A Rezabakhsh","year":"2020","unstructured":"Rezabakhsh A, Rahbarghazi R, Fathi F (2020) Surface plasmon resonance biosensors for detection of Alzheimer\u2019s biomarkers; an effective step in early and accurate diagnosis. Biosens Bioelectron 167:112511. https:\/\/doi.org\/10.1016\/j.bios.2020.112511","journal-title":"Biosens Bioelectron"},{"key":"1330_CR208","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejrad.2017.07.014","volume":"94","author":"L Rice","year":"2017","unstructured":"Rice L, Bisdas S (2017) The diagnostic value of FDG and amyloid PET in Alzheimer\u2019s disease: a systematic review. Eur J Radiol 94:16\u201324. https:\/\/doi.org\/10.1016\/j.ejrad.2017.07.014","journal-title":"Eur J Radiol"},{"key":"1330_CR209","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX et al (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141:2181\u20132193. https:\/\/doi.org\/10.1093\/brain\/awy146","journal-title":"Brain"},{"key":"1330_CR210","doi-asserted-by":"publisher","DOI":"10.1186\/s43055-020-00164-8","author":"SHS Saad","year":"2020","unstructured":"Saad SHS, Alashwah MMA, Alsafa AA, Dawoud MA (2020) The role of brain structural magnetic resonance imaging in the assessment of hippocampal subfields in Alzheimer\u2019s disease. Egypt J Radiol Nucl Med. https:\/\/doi.org\/10.1186\/s43055-020-00164-8","journal-title":"Egypt J Radiol Nucl Med"},{"key":"1330_CR211","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/S1980-5764-2016DN1002003","volume":"10","author":"LP Schilling","year":"2016","unstructured":"Schilling LP, Zimmer ER, Shin M et al (2016) Imaging Alzheimer\u2019s disease pathophysiology with PET. Dement Neuropsychol 10:79\u201390. https:\/\/doi.org\/10.1590\/S1980-5764-2016DN1002003","journal-title":"Dement Neuropsychol"},{"key":"1330_CR212","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR et al (2016) PET imaging of tau deposition in the aging human brain. Neuron 89:971\u2013982. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.028","journal-title":"Neuron"},{"key":"1330_CR213","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2021.792227","volume":"12","author":"A Schumacher-Schuh","year":"2022","unstructured":"Schumacher-Schuh A, Bieger A, Borelli WV et al (2022) Advances in proteomic and metabolomic profiling of neurodegenerative diseases. Front Neurol 12:1\u201314. https:\/\/doi.org\/10.3389\/fneur.2021.792227","journal-title":"Front Neurol"},{"key":"1330_CR214","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disesaes. JAMA 303:1832\u20131840","journal-title":"JAMA"},{"key":"1330_CR215","doi-asserted-by":"publisher","first-page":"01","DOI":"10.7860\/JCDR\/2016\/18828.8166","volume":"10","author":"N Sharma","year":"2016","unstructured":"Sharma N, Singh AN (2016) Exploring biomarkers for Alzheimer\u2019s disease. J Clin Diagn Res 10:01\u201306. https:\/\/doi.org\/10.7860\/JCDR\/2016\/18828.8166","journal-title":"J Clin Diagn Res"},{"key":"1330_CR216","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/e20010021","volume":"20","author":"S Simons","year":"2018","unstructured":"Simons S, Espino P, Ab\u00e1solo D (2018) Fuzzy entropy analysis of the electroencephalogram in patients with Alzheimer\u2019s disease: is the method superior to sample entropy? Entropy 20:21","journal-title":"Entropy"},{"key":"1330_CR217","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.conb.2019.11.019","volume":"61","author":"J Simr\u00e9n","year":"2020","unstructured":"Simr\u00e9n J, Ashton NJ, Blennow K, Zetterberg H (2020) An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead. Curr Opin Neurobiol 61:29\u201339. https:\/\/doi.org\/10.1016\/j.conb.2019.11.019","journal-title":"Curr Opin Neurobiol"},{"key":"1330_CR218","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3906\/sag-1406-134","volume":"45","author":"FB \u015eirin","year":"2015","unstructured":"\u015eirin FB, Kumbul Do\u011fuc D, Vural H et al (2015) Plasma 8-isoPGF2\u03b1 and serum melatonin levels in patients with minimal cognitive impairment and Alzheimer disease. Turk J Med Sci 45:1073\u20131077. https:\/\/doi.org\/10.3906\/sag-1406-134","journal-title":"Turk J Med Sci"},{"key":"1330_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-021-02267-5","volume":"22","author":"H Specht","year":"2021","unstructured":"Specht H, Emmott E, Petelski AA et al (2021) Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2. Genome Biol 22:1\u201328. https:\/\/doi.org\/10.1186\/s13059-021-02267-5","journal-title":"Genome Biol"},{"key":"1330_CR220","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/brain\/awab099","volume":"144","author":"S Spina","year":"2021","unstructured":"Spina S, La Joie R, Petersen C et al (2021) Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease. Brain 144:2186\u20132198. https:\/\/doi.org\/10.1093\/brain\/awab099","journal-title":"Brain"},{"key":"1330_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.snb.2020.128146","author":"T \u0160pringer","year":"2020","unstructured":"\u0160pringer T, Hemmerov\u00e1 E, Finocchiaro G et al (2020) Surface plasmon resonance biosensor for the detection of tau-amyloid \u03b2 complex. Sens Actuators B. https:\/\/doi.org\/10.1016\/j.snb.2020.128146","journal-title":"Sens Actuators B"},{"key":"1330_CR222","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","volume":"62","author":"R Sultana","year":"2013","unstructured":"Sultana R, Perluigi M, Butterfield DA (2013) Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med 62:157\u2013169. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.09.027","journal-title":"Free Radic Biol Med"},{"key":"1330_CR223","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics9020065","author":"S Suppiah","year":"2019","unstructured":"Suppiah S, Didier MA, Vinjamuri S (2019) The who, when, why, and how of PET amyloid imaging in management of Alzheimer\u2019s disease-review of literature and interesting images. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics9020065","journal-title":"Diagnostics"},{"key":"1330_CR224","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1600-0404.2011.01592.x","volume":"125","author":"F Tabaraud","year":"2012","unstructured":"Tabaraud F, Leman JP, Milor AM et al (2012) Alzheimer CSF biomarkers in routine clinical setting. Acta Neurol Scand 125:416\u2013423. https:\/\/doi.org\/10.1111\/j.1600-0404.2011.01592.x","journal-title":"Acta Neurol Scand"},{"key":"1330_CR225","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/rcm.1290020802","volume":"2","author":"K Tanaka","year":"1988","unstructured":"Tanaka K, Waki H, Ido Y et al (1988) Protein and polymer analyses up to m\/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2:151\u2013153. https:\/\/doi.org\/10.1002\/rcm.1290020802","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1330_CR226","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jalz.2018.06.3058","volume":"15","author":"Y Tang","year":"2019","unstructured":"Tang Y, Lutz MW, Xing Y (2019) A systems-based model of Alzheimer\u2019s disease. Alzheimer\u2019s Dement 15:168\u2013171. https:\/\/doi.org\/10.1016\/j.jalz.2018.06.3058","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR227","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, Carare RO, Osorio RS et al (2015) Clearance systems in the brain: implications for Alzheimer disease. Nat Rev Neurol 11:457\u2013470. https:\/\/doi.org\/10.1038\/nrneurol.2015.119","journal-title":"Nat Rev Neurol"},{"key":"1330_CR228","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1474-4422(15)00093-9","volume":"14","author":"S Teipel","year":"2015","unstructured":"Teipel S, Drzezga A, Grothe MJ et al (2015) Multimodal imaging in Alzheimer\u2019s disease: validity and usefulness for early detection. Lancet Neurol 14:1037\u20131053. https:\/\/doi.org\/10.1016\/S1474-4422(15)00093-9","journal-title":"Lancet Neurol"},{"key":"1330_CR229","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH et al (2022) Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol 21:66\u201377","journal-title":"Lancet Neurol"},{"key":"1330_CR230","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.dadm.2018.12.003","volume":"11","author":"C Tochel","year":"2019","unstructured":"Tochel C, Smith M, Baldwin H et al (2019) What outcomes are important to patients with mild cognitive impairment or Alzheimer\u2019s disease, their caregivers, and health-care professionals? A systematic review. Alzheimer\u2019s Dement Diagn Assess Dis Monit 11:231\u2013247. https:\/\/doi.org\/10.1016\/j.dadm.2018.12.003","journal-title":"Alzheimer\u2019s Dement Diagn Assess Dis Monit"},{"key":"1330_CR231","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","volume":"6","author":"JQ Trojanowski","year":"2010","unstructured":"Trojanowski JQ, Vandeerstichele H, Korecka M et al (2010) Update on the biomarker core of the Alzheimer\u2019s Disease Neuroimaging Initiative subjects. Alzheimer\u2019s Dement 6:230\u2013238. https:\/\/doi.org\/10.1016\/j.jalz.2010.03.008","journal-title":"Alzheimer\u2019s Dement"},{"key":"1330_CR232","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","volume":"1842","author":"E Trushina","year":"2014","unstructured":"Trushina E, Mielke MM (2014) Recent advances in the application of metabolomics to Alzheimer\u2019s Disease. Biochim Biophys Acta 1842:1232\u20131239. https:\/\/doi.org\/10.1016\/j.bbadis.2013.06.014","journal-title":"Biochim Biophys Acta"},{"key":"1330_CR233","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0361-9230(01)00450-6","volume":"54","author":"EE Tuppo","year":"2001","unstructured":"Tuppo EE, Forman LJ, Spur BW et al (2001) Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer\u2019s disease. Brain Res Bull 54:565\u2013568. https:\/\/doi.org\/10.1016\/S0361-9230(01)00450-6","journal-title":"Brain Res Bull"},{"key":"1330_CR234","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM (2019) \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegener 14:1\u201319. https:\/\/doi.org\/10.1186\/s13024-019-0320-x","journal-title":"Mol Neurodegener"},{"key":"1330_CR235","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H, Ekstr\u00f6m K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654\u2013659. https:\/\/doi.org\/10.1038\/ncb1596","journal-title":"Nat Cell Biol"},{"key":"1330_CR236","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12149-018-1292-6","volume":"32","author":"V Valotassiou","year":"2018","unstructured":"Valotassiou V, Malamitsi J, Papatriantafyllou J et al (2018) SPECT and PET imaging in Alzheimer\u2019s disease. Ann Nucl Med 32:583\u2013593. https:\/\/doi.org\/10.1007\/s12149-018-1292-6","journal-title":"Ann Nucl Med"},{"key":"1330_CR237","doi-asserted-by":"publisher","first-page":"101732","DOI":"10.1016\/j.pneurobio.2019.101732","volume":"185","author":"MMJ van den Berg","year":"2020","unstructured":"van den Berg MMJ, Krauskopf J, Ramaekers JG et al (2020) Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol 185:101732. https:\/\/doi.org\/10.1016\/j.pneurobio.2019.101732","journal-title":"Prog Neurobiol"},{"key":"1330_CR238","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/hipo.20615","volume":"19","author":"K Van Leemput","year":"2009","unstructured":"Van Leemput K, Bakkour A, Benner T et al (2009) Automated segmentation of hippocampal subfields from ultra-high resolution in vivo MRI. Hippocampus 19:549\u2013557. https:\/\/doi.org\/10.1002\/hipo.20615","journal-title":"Hippocampus"},{"key":"1330_CR239","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/927573","author":"F Vecchio","year":"2011","unstructured":"Vecchio F, Lizio R, Frisoni GB et al (2011) Electroencephalographic rhythms in alzheimer\u2019s disease. Int J Alzheimers Dis. https:\/\/doi.org\/10.4061\/2011\/927573","journal-title":"Int J Alzheimers Dis"},{"key":"1330_CR240","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt47","author":"P Vemuri","year":"2010","unstructured":"Vemuri P, Jack CR (2010) Role of structural MRI in Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. https:\/\/doi.org\/10.1186\/alzrt47","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1330_CR241","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.25334","volume":"84","author":"IMW Verberk","year":"2018","unstructured":"Verberk IMW, Slot RE, Verfaillie SCJ et al (2018) Plasma amyloid as prescreener for the earliest Alzheimer pathological changes. Ann Neurol 84:648\u2013658. https:\/\/doi.org\/10.1002\/ana.25334","journal-title":"Ann Neurol"},{"key":"1330_CR242","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11571-014-9325-x","volume":"9","author":"R Wang","year":"2015","unstructured":"Wang R, Wang J, Yu H et al (2015) Power spectral density and coherence analysis of Alzheimer\u2019s EEG. Cogn Neurodyn 9:291\u2013304. https:\/\/doi.org\/10.1007\/s11571-014-9325-x","journal-title":"Cogn Neurodyn"},{"key":"1330_CR243","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","volume":"86","author":"H Wellington","year":"2016","unstructured":"Wellington H, Paterson RW, Portelius E et al (2016) Increased CSF neurogranin concentration is specific to Alzheimer disease. Neurology 86:829\u2013835. https:\/\/doi.org\/10.1212\/WNL.0000000000002423","journal-title":"Neurology"},{"key":"1330_CR244","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/10408363.2019.1670613","volume":"57","author":"KEJ Wesenhagen","year":"2020","unstructured":"Wesenhagen KEJ, Teunissen CE, Visser PJ, Tijms BM (2020) Cerebrospinal fluid proteomics and biological heterogeneity in Alzheimer\u2019s disease: a literature review. Crit Rev Clin Lab Sci 57:86\u201398. https:\/\/doi.org\/10.1080\/10408363.2019.1670613","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1330_CR245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2017.00719","volume":"8","author":"JM Wilkins","year":"2018","unstructured":"Wilkins JM, Trushina E (2018) Application of metabolomics in Alzheimer\u2019s disease. Front Neurol 8:1\u201320. https:\/\/doi.org\/10.3389\/fneur.2017.00719","journal-title":"Front Neurol"},{"key":"1330_CR246","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-statistics-022513-115611.Brain","volume":"23","author":"MS Wilson","year":"2012","unstructured":"Wilson MS, Metink-Kane MM (2012) \u57fa\u56e0\u7684\u6539\u53d8NIH Public Access. Bone 23:1\u20137. https:\/\/doi.org\/10.1146\/annurev-statistics-022513-115611.Brain","journal-title":"Bone"},{"key":"1330_CR247","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.00818.x","volume":"81","author":"J Wiltfang","year":"2002","unstructured":"Wiltfang J, Esselmann H, Bibl M et al (2002) Highly conserved and disease-specific patterns of carboxyterminally truncated A\u03b2 peptides 1\u201337\/38\/39 in addition to 1\u201340\/42 in Alzheimer\u2019s disease and in patients with chronic neuroinflammation. J Neurochem 81:481\u2013496","journal-title":"J Neurochem"},{"key":"1330_CR248","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1088\/0031-9155\/57\/9\/2619","volume":"57","author":"R Wyllie","year":"2012","unstructured":"Wyllie R, Kauer M, Smetana GS et al (2012) Magnetocardiography with a modular spin-exchange relaxation-free atomic magnetometer array. Phys Med Biol 57:2619\u20132632. https:\/\/doi.org\/10.1088\/0031-9155\/57\/9\/2619","journal-title":"Phys Med Biol"},{"key":"1330_CR249","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/cns.13730","volume":"27","author":"X Xiao","year":"2021","unstructured":"Xiao X, Guo L, Liao X et al (2021) The role of vascular dementia associated genes in patients with Alzheimer\u2019s disease: a large case\u2013control study in the Chinese population. CNS Neurosci Ther 27:1531\u20131539. https:\/\/doi.org\/10.1111\/cns.13730","journal-title":"CNS Neurosci Ther"},{"key":"1330_CR250","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1214\/17-STS622","volume":"32","author":"X Yan","year":"2017","unstructured":"Yan X, Bien J (2017) Hierarchical sparse modeling: a choice of two group lasso formulations. Stat Sci 32:531\u2013560","journal-title":"Stat Sci"},{"key":"1330_CR251","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.5213\/inj.1938184.092","volume":"23","author":"SH Yang","year":"2019","unstructured":"Yang SH (2019) Cellular and molecular mediators of neuroinflammation in Alzheimer disease. Int Neurourol J 23:S54\u2013S62. https:\/\/doi.org\/10.5213\/inj.1938184.092","journal-title":"Int Neurourol J"},{"key":"1330_CR252","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"CC Yang","year":"2018","unstructured":"Yang CC, Chiu MJ, Chen TF et al (2018) Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 61:1323\u20131332. https:\/\/doi.org\/10.3233\/JAD-170810","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1330_CR253","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1109\/TBME.2019.2898871","volume":"66","author":"S Yang","year":"2019","unstructured":"Yang S, Bornot JMS, Wong-Lin K, Prasad G (2019) M\/EEG-based bio-markers to predict the MCI and Alzheimer\u2019s disease: a review from the ML perspective. IEEE Trans Biomed Eng 66:2924\u20132935","journal-title":"IEEE Trans Biomed Eng"},{"key":"1330_CR254","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/14737159.2017.1341313","volume":"17","author":"A Yilmaz","year":"2017","unstructured":"Yilmaz A, Blennow K, Hagberg L et al (2017) Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls. Expert Rev Mol Diagn 17:761\u2013770. https:\/\/doi.org\/10.1080\/14737159.2017.1341313","journal-title":"Expert Rev Mol Diagn"},{"key":"1330_CR255","doi-asserted-by":"publisher","first-page":"101491","DOI":"10.1016\/j.arr.2021.101491","volume":"72","author":"SQ Yoong","year":"2021","unstructured":"Yoong SQ, Lu J, Xing H et al (2021) The prognostic utility of CSF neurogranin in predicting future cognitive decline in the Alzheimer\u2019s disease continuum: a systematic review and meta-analysis with narrative synthesis. Ageing Res Rev 72:101491. https:\/\/doi.org\/10.1016\/j.arr.2021.101491","journal-title":"Ageing Res Rev"},{"key":"1330_CR256","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-020-01978-9","volume":"20","author":"SY Yu","year":"2020","unstructured":"Yu SY, Lian TH, Guo P et al (2020) Correlations of apathy with clinical symptoms of Alzheimer\u2019s disease and olfactory dysfunctions: a cross-sectional study. BMC Neurol 20:1\u20138. https:\/\/doi.org\/10.1186\/s12883-020-01978-9","journal-title":"BMC Neurol"},{"key":"1330_CR257","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.etap.2005.03.007","volume":"20","author":"F Zahir","year":"2005","unstructured":"Zahir F, Rizwi SJ, Haq SK, Khan RH (2005) Low dose mercury toxicity and human health. Environ Toxicol Pharmacol 20:351\u2013360","journal-title":"Environ Toxicol Pharmacol"},{"key":"1330_CR258","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","volume":"65","author":"H Zetterberg","year":"2008","unstructured":"Zetterberg H, Andreasson U, Hansson O et al (2008) Elevated cerebrospinal fluid BACE1 activity in incipient alzheimer disease. Arch Neurol 65:1102\u20131107. https:\/\/doi.org\/10.1001\/archneur.65.8.1102","journal-title":"Arch Neurol"},{"key":"1330_CR259","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40708-015-0028-9","volume":"3","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Chen X, Zhou Y (2016) Quantitative multimodal multiparametric imaging in Alzheimer\u2019s disease. Brain Inform 3:29\u201337. https:\/\/doi.org\/10.1007\/s40708-015-0028-9","journal-title":"Brain Inform"},{"key":"1330_CR260","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/cjn.2014.15","volume":"41","author":"ER Zimmer","year":"2014","unstructured":"Zimmer ER, Leuzy A, Gauthier S, Rosa-Neto P (2014) Developments in tau PET imaging. Can J Neurol Sci 41:547\u2013553. https:\/\/doi.org\/10.1017\/cjn.2014.15","journal-title":"Can J Neurol Sci"},{"key":"1330_CR261","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.2147\/NDT.S172285","volume":"14","author":"M Zv\u011b\u0159ov\u00e1","year":"2018","unstructured":"Zv\u011b\u0159ov\u00e1 M (2018) Alzheimer\u2019s disease and blood-based biomarkers: potential contexts of use. Neuropsychiatr Dis Treat 14:1877\u20131882. https:\/\/doi.org\/10.2147\/NDT.S172285","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01330-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-023-01330-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01330-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T23:31:53Z","timestamp":1689031913000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-023-01330-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":261,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1007\/s10571-023-01330-y","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Dikshi Gupta is\/was employed by JoyScore Inc., 2440 Cerritos Ave, Signal Hill, CA 90755, USA. We hereby declare that JoyScore Inc. has no role in designing, drafting, and conception of the work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read and approved the final manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}